Synthetic Biology


Click here to see how Octant is applying RIPTIDE to high throughput rational drug design.

“ We needed a robust, scalable, and low touch method for verifying full plasmid sequences…ideally, one that would not require a huge investment in labor and capital. We found RIPTIDE!

- Sri Kosuri, Founder and CEO of Octant

More Throughput

<$10 per sample
½ reaction volumes optional

Simple Workflow

No fragmentation.
No ligation.
No normalization.

Better Data

Validated analysis pipeline.

Ready to find out more?

Get in touch now.

Scroll to Top